Trials / Completed
CompletedNCT01588535
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
Phase 2, Multicenter, Placebo-controlled, Double-masked, Randomized Study to Demonstrate Reliability and Validity of FAECC Scale (Modified FLACC) to Evaluate Relief of Pain in Subjects With Acute Otitis Media Aged >/=2 Months to <5 Years
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Arbor Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 2 Months – 4 Years
- Healthy volunteers
- Not accepted
Summary
This study is to assess the reliability and validity of the FAECC scale to evaluate pain associated with acute otitis media in children aged 2 months to 5 years.
Detailed description
to assess the reliability and validity of the FAECC pain scale tool in children aged 2 months to 5 years with acute otitis media given AR01 or placebo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | benzocaine | benzocaine 10 mg/mL, five drops in affected ear canal each hour as needed |
| DRUG | placebo | placebo solution, five drops in affected ear canal each hour as needed |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2012-05-01
- Last updated
- 2015-05-04
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01588535. Inclusion in this directory is not an endorsement.